Complement C5 Protein as a Marker of Subclinical Atherosclerosis

Abstract

Activation of the complement system is a major alteration in early atherosclerotic plaques and is reflected by increased C5 plasma levels, which have promising value as a novel circulating biomarker of subclinical atherosclerosis.